Contraceptive implants used by cat breeders in France: a study of 140 purebred cats

Objectives Deslorelin 4.7 mg and melatonin 18 mg subcutaneous implants were studied in purebred male and female cats, via questionnaires sent to French cat breeders, to assess breed, age, duration of the contraceptive effect, fertility after use, changes in behaviour and side effects. Methods Reproductive data were collected in 57 tom cats and 41 queens implanted with deslorelin 4.7 mg, and 42 queens implanted with melatonin 18 mg, for a total of 140 purebred cats, from 38 different catteries, representing 18 breeds. Results Using deslorelin (Suprelorin 4.7 mg; Virbac), sexual behaviour in males was inhibited for a mean ± SD of 13.4 ± 3.2 (range 8–21) months in 37/57 cats. Of these, 24/37 mated successfully and produced litters at a mean of 15.5 ± 3.6 (range 9–20) months. Inhibition lasted 11 ± 1.1 (range 9–12; n = 6), 13.2 ± 2.4 (range 12–18; n = 6) and 15 ± 3.5 (range 9–18; n = 6) months in Norwegian Forest Cat, Singapura and Ragdoll males, respectively. In 26/41 females implanted with deslorelin 4.7 mg, oestrus was inhibited for a mean of 16.0 ± 5.7 (8–38) months; 12/26 went on to produce a litter. Of the side effects specific to females: two presented persistent oestrus, leading to the removal of the implant; two developed lactation; one had fibroadenomatosis; and one was sterilised owing to cystic endometrial hyperplasia. Using melatonin (Melovine 18 mg; Ceva), 33/42 females had oestrus inhibited for a mean of 86 ± 50 (range 21–277) days after implantation with a peak return to oestrus in March, and 12/33 had a subsequent litter. No side effects were reported. Conclusions and relevance This study is the first to collect a large amount of field data, in 140 purebred male and female cats where a deslorelin 4.7 mg or a melatonin 18 mg implant was used. These field results may allow for more accurate clinical advice and open up new avenues of research.

[1]  S. Romagnoli,et al.  Fertility parameters and reproductive management of Norwegian Forest Cats, Maine Coon, Persian and Bengal cats raised in Italy: a questionnaire-based study , 2019, Journal of feline medicine and surgery.

[2]  R. L. de la Sota,et al.  Reestablishment of sperm quality after long-term deslorelin suppression in tomcats. , 2018, Animal reproduction science.

[3]  S. Walker,et al.  ASSESSING THE EFFICACY OF DESLORELIN ACETATE IMPLANTS (SUPRELORIN) IN ALTERNATIVE PLACEMENT SITES , 2018, Journal of zoo and wildlife medicine.

[4]  L. Rhodes New approaches to non-surgical sterilization for dogs and cats: Opportunities and challenges. , 2017, Reproduction in domestic animals = Zuchthygiene.

[5]  S. Goericke-Pesch Long-term effects of GnRH agonists on fertility and behaviour. , 2017, Reproduction in domestic animals = Zuchthygiene.

[6]  S. Romagnoli,et al.  Postponement of puberty in queens treated with deslorelin , 2017, Journal of feline medicine and surgery.

[7]  J. Thuróczy,et al.  Effect of deslorelin on testicular function, serum dihydrotestosterone and oestradiol concentrations during and after suppression of sexual activity in tom cats , 2017, Journal of feline medicine and surgery.

[8]  S. Schäfer-Somi Effect of melatonin on the reproductive cycle in female cats: a review of clinical experiences and previous studies , 2017, Journal of feline medicine and surgery.

[9]  M. Khalid,et al.  GnRH-agonist implantation of prepubertal male cats affects their reproductive performance and testicular LH receptor and FSH receptor expression. , 2016, Theriogenology.

[10]  D. Zambelli,et al.  First deliveries after estrus induction using deslorelin and endoscopic transcervical insemination in the queen. , 2015, Theriogenology.

[11]  S. Romagnoli Progestins to control feline reproduction , 2015, Journal of feline medicine and surgery.

[12]  S. Johnston,et al.  No surgery required: the future of feline sterilization , 2015, Journal of feline medicine and surgery.

[13]  C. Fontaine Long-term contraception in a small implant , 2015, Journal of feline medicine and surgery.

[14]  M. Kutzler Alternative methods for feline fertility control , 2015, Journal of feline medicine and surgery.

[15]  P. Fernández,et al.  Histologic effect of a postnatal slow-release GnRH agonist on feline gonads. , 2015, Theriogenology.

[16]  P. Čížek,et al.  Azoospermia with variable testicular histology after 7 months of treatment with a deslorelin implant in toms. , 2015, Theriogenology.

[17]  M. C. Stornelli,et al.  Effect of melatonin implants on spermatogenesis in the domestic cat (Felis silvestris catus). , 2014, Theriogenology.

[18]  M. Merlo,et al.  Effect of GnRH analogs in postnatal domestic cats. , 2014, Theriogenology.

[19]  A. Wehrend,et al.  Suppression of fertility in adult cats. , 2014, Reproduction in domestic animals = Zuchthygiene.

[20]  N. Santos,et al.  Suppression of fertility in adult dogs. , 2014, Reproduction in domestic animals = Zuchthygiene.

[21]  A. Wehrend,et al.  Reversibility of germinative and endocrine testicular function after long-term contraception with a GnRH-agonist implant in the tom-a follow-up study. , 2014, Theriogenology.

[22]  A. Wehrend,et al.  Basal testosterone concentrations after the application of a slow-release GnRH agonist implant are associated with a loss of response to buserelin, a short-term GnRH agonist, in the tom cat. , 2013, Theriogenology.

[23]  A. Wehrend,et al.  Treatment with Suprelorin in a pregnant cat , 2013, Journal of feline medicine and surgery.

[24]  A. Wehrend,et al.  Treatment of queens in estrus and after estrus with a GnRH-agonist implant containing 4.7 mg deslorelin; hormonal response, duration of efficacy, and reversibility. , 2013, Theriogenology.

[25]  C. Barbeito,et al.  Long-term-release GnRH agonists postpone puberty in domestic cats. , 2012, Reproduction in domestic animals = Zuchthygiene.

[26]  K. Reynaud,et al.  Results of GnRH agonist implants in oestrous induction and oestrous suppression in bitches and queens. , 2012, Reproduction in domestic animals = Zuchthygiene.

[27]  S. Romagnoli,et al.  Semen quality and onset of sterility following administration of a 4.7-mg deslorelin implant in adult male dogs. , 2012, Reproduction in domestic animals = Zuchthygiene.

[28]  E. Trevisol,et al.  Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens. , 2012, Theriogenology.

[29]  P. Čížek,et al.  Reversible suppression of sexual activity in tomcats with deslorelin implant. , 2012, Theriogenology.

[30]  C. Gobello,et al.  Domestic queens under natural temperate photoperiod do not manifest seasonal anestrus. , 2011, Animal reproduction science.

[31]  C. Gobello,et al.  Long-term melatonin treatment prolongs interestrus, but does not delay puberty, in domestic cats. , 2011, Theriogenology.

[32]  A. Wehrend,et al.  Clinical efficacy of a GnRH-agonist implant containing 4.7 mg deslorelin, Suprelorin, regarding suppression of reproductive function in tomcats. Sandra.Pesch@vetmed.uni-giessen.de. , 2011, Theriogenology.

[33]  R. L. de la Sota,et al.  Suppression of estrus in cats with melatonin implants. , 2009, Theriogenology.

[34]  A. Keskin,et al.  Pathological abnormalities after long-term administration of medroxyprogesterone acetate in a queen , 2009, Journal of feline medicine and surgery.

[35]  B. Uslu,et al.  Effects of melatonin on the onset of ovarian activity in Turkish Van cats. , 2009 .

[36]  Julie C Bulman-Fleming A rare case of uterine adenomyosis in a Siamese cat. , 2008, The Canadian veterinary journal = La revue veterinaire canadienne.

[37]  E. Axnér Updates on reproductive physiology, genital diseases and artificial insemination in the domestic cat. , 2008, Reproduction in domestic animals = Zuchthygiene.

[38]  D. Shaw,et al.  Feline diabetes mellitus in the UK: The prevalence within an insured cat population and a questionnaire-based putative risk factor analysis , 2007, Journal of feline medicine and surgery.

[39]  T. Trigg,et al.  A review of advances in the use of the GnRH agonist deslorelin in control of reproduction. , 2006, Theriogenology.

[40]  A. Padula GnRH analogues--agonists and antagonists. , 2005, Animal reproduction science.

[41]  L. Peña,et al.  First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases , 2004, Breast Cancer Research.

[42]  L. MacDougall Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate. , 2003, The Canadian veterinary journal = La revue veterinaire canadienne.

[43]  H. Kooistra,et al.  Treatment of fibroadenomatous hyperplasia in cats with aglépristone. , 2002, Journal of veterinary internal medicine.

[44]  A. Gruber,et al.  Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist , 2001, Veterinary Record.

[45]  G. Martin,et al.  Suppression of the oestrous responses of bitches to the GnRH analogue deslorelin by progestin. , 2001, Journal of reproduction and fertility. Supplement.

[46]  E. van Garderen,et al.  Growth hormone mRNA in mammary gland tumors of dogs and cats. , 1995, The Journal of clinical investigation.

[47]  A. Hart,et al.  Feline mammary tumors: a case-control study of hormonal factors. , 1991, Anticancer research.

[48]  C. Bellenger,et al.  Effect of megestrol acetate on the endometrium of the prepubertally ovariectomised kitten. , 1990, Research in Veterinary Science.

[49]  D. Church,et al.  Comparative effects of proligestone and megestrol acetate on basal plasma glucose concentrations and cortisol responses to exogenous adrenocorticotrophic hormone in cats. , 1989, Research in veterinary science.

[50]  D. W. Hayden,et al.  Morphologic Changes in the Mammary Gland of Megestrol Acetate-treated and Untreated Cats: A Retrospective Study , 1989, Veterinary pathology.

[51]  M. Peterson Effects of megestrol acetate on glucose tolerance and growth hormone secretion in the cat. , 1987, Research in veterinary science.

[52]  Watson Ad,et al.  Glucose intolerance in cats given short-term therapies of prednisolone and megestrol acetate. , 1985 .

[53]  D. J. Middleton,et al.  Glucose intolerance in cats given short-term therapies of prednisolone and megestrol acetate. , 1985, American journal of veterinary research.

[54]  E. Angelopoulos,et al.  Feline mammary carcinoma: a retrospective evaluation of 17 cases. , 1984, The Canadian veterinary journal = La revue veterinaire canadienne.

[55]  B. Claustrat,et al.  Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. , 1982, Acta endocrinologica.

[56]  Pukay Bp A hyperglycemia-glucosuria syndrome in cats following megestrol acetate therapy. , 1979 .

[57]  B. Pukay A hyperglycemia-glucosuria syndrome in cats following megestrol acetate therapy. , 1979, The Canadian veterinary journal = La revue veterinaire canadienne.

[58]  A. Schally,et al.  Gonadotrophin releasing hormone analogues. , 1978, Annals of clinical research.

[59]  B. Fernandez,et al.  Feline mammary carcinoma and progestogens. , 1975, Feline practice.

[60]  D. A. Thornton,et al.  Uterine cystic hyperplasia in a siamese Cat following treatment with medroxyprogesterone , 1967, The Veterinary Record.